Mainz Biomed B.V. (MYNZ)
MYNZ Stock Price Chart
Explore Mainz Biomed B.V. interactive price chart. Choose custom timeframes to analyze MYNZ price movements and trends.
MYNZ Company Profile
Discover essential business fundamentals and corporate details for Mainz Biomed B.V. (MYNZ) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
5 Nov 2021
Employees
19.00
Website
https://mainzbiomed.comCEO
Guido Baechler
Description
Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic (IVD) and research use only tests for clinical diagnostics in human genetics. It offers ColoAlert, a colorectal cancer screening test; PancAlert, a product candidate for a pancreatic cancer screening test; GenoStrip to detect pathogens in environments on a molecular genetic basis; and research-use-only and IVD tests. The company was founded in 2008 and is based in Mainz, Germany.
MYNZ Financial Timeline
Browse a chronological timeline of Mainz Biomed B.V. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 3 Sept 2025
Revenue for the quarter reached $497.05K , meeting expectations.
Earnings released on 8 Apr 2025
EPS came in at -$9.60 falling short of the estimated -$3.60 by -166.67%, while revenue for the quarter reached $373.22K .
Earnings released on 26 Dec 2024
EPS came in at -$15.60 falling short of the estimated -$4.40 by -254.55%, while revenue for the quarter reached $520.77K , missing expectations by -13.20%.
Stock split effective on 3 Dec 2024
Shares were split 1 : 40 , changing the number of shares outstanding and the price per share accordingly.
Stock split effective on 3 Dec 2024
Shares were split 1 : 40 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 9 Apr 2024
EPS came in at -$9.60 falling short of the estimated -$0.32 by -2.90K%, while revenue for the quarter reached $214.76K , missing expectations by -2.38%.
Earnings released on 16 Nov 2023
EPS came in at -$15.60 surpassing the estimated -$20.00 by +22.00%, while revenue for the quarter reached $500.21K , beating expectations by +100.08%.
Earnings released on 16 May 2023
EPS came in at -$18.00 surpassing the estimated -$18.80 by +4.26%, while revenue for the quarter reached $251.40K , missing expectations by -5.73%.
Earnings released on 2 Nov 2022
EPS came in at -$0.97 falling short of the estimated -$0.43 by -125.90%, while revenue for the quarter reached $278.48K .
Earnings released on 2 May 2022
EPS came in at -$1.30 , while revenue for the quarter reached $160.04K .
Earnings released on 30 Jun 2021
EPS came in at -$0.02 , while revenue for the quarter reached $417.31K .
Earnings released on 31 Dec 2020
EPS came in at -$0.01 , while revenue for the quarter reached $246.78K .
MYNZ Stock Performance
Access detailed MYNZ performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.